381 related articles for article (PubMed ID: 20527025)
1. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
3. Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa.
Bauer-Hofmann R; Borghouts C; Auvinen E; Bourda E; Rösl F; Alonso A
Virology; 1996 Mar; 217(1):33-41. PubMed ID: 8599218
[TBL] [Abstract][Full Text] [Related]
4. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.
Peter M; Rosty C; Couturier J; Radvanyi F; Teshima H; Sastre-Garau X
Oncogene; 2006 Sep; 25(44):5985-93. PubMed ID: 16682952
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of cellular loci disrupted by papillomavirus 16 integration in cervical cancer: frequent viral integration in topologically destabilized and transcriptionally active chromosomal regions.
Choo KB; Chen CM; Han CP; Cheng WT; Au LC
J Med Virol; 1996 May; 49(1):15-22. PubMed ID: 8732866
[TBL] [Abstract][Full Text] [Related]
6. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
7. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors.
Thorland EC; Myers SL; Gostout BS; Smith DI
Oncogene; 2003 Feb; 22(8):1225-37. PubMed ID: 12606949
[TBL] [Abstract][Full Text] [Related]
8. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
9. Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines.
Koopman LA; Szuhai K; van Eendenburg JD; Bezrookove V; Kenter GG; Schuuring E; Tanke H; Fleuren GJ
Cancer Res; 1999 Nov; 59(21):5615-24. PubMed ID: 10554043
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
12. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions.
Wentzensen N; Ridder R; Klaes R; Vinokurova S; Schaefer U; Doeberitz Mv
Oncogene; 2002 Jan; 21(3):419-26. PubMed ID: 11821954
[TBL] [Abstract][Full Text] [Related]
13. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
14. Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.
Einstein MH; Cruz Y; El-Awady MK; Popescu NC; DiPaolo JA; van Ranst M; Kadish AS; Romney S; Runowicz CD; Burk RD
Clin Cancer Res; 2002 Feb; 8(2):549-54. PubMed ID: 11839676
[TBL] [Abstract][Full Text] [Related]
15. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
Alazawi W; Pett M; Arch B; Scott L; Freeman T; Stanley MA; Coleman N
Cancer Res; 2002 Dec; 62(23):6959-65. PubMed ID: 12460913
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.
Thorland EC; Myers SL; Persing DH; Sarkar G; McGovern RM; Gostout BS; Smith DI
Cancer Res; 2000 Nov; 60(21):5916-21. PubMed ID: 11085503
[TBL] [Abstract][Full Text] [Related]
18. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
19. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.
Herrick J; Conti C; Teissier S; Thierry F; Couturier J; Sastre-Garau X; Favre M; Orth G; Bensimon A
Cancer Res; 2005 Feb; 65(4):1174-9. PubMed ID: 15735000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
